Prevention and management of intrathecal drug delivery and spinal cord stimulation system infections.
about
Intrathecal Drug Delivery (ITDD) systems for cancer painSubarachnoid hemorrhage and the distribution of drugs delivered into the cerebrospinal fluid. Laboratory investigationIntrathecal analgesia and palliative care: a case studyBest practices for intrathecal drug delivery for pain.Spinal cord stimulation for neuropathic pain: an evidence-based analysis.Neuraxial (epidural and intrathecal) opioids for intractable pain.Introduction of infection control measures to reduce infection associated with implantable pain therapy devices.Retrospective review of 707 cases of spinal cord stimulation: indications and complications.Using the SAFE principles when evaluating electrical stimulation therapies for the pain of failed back surgery syndrome.Avoiding complications from spinal cord stimulation: practical recommendations from an international panel of experts.Medicinal chemistry based approaches and nanotechnology-based systems to improve CNS drug targeting and delivery.Effect of a novel fixation method for spinal cord stimulators.Spinal cord stimulation as treatment for complex regional pain syndrome should be considered earlier than last resort therapy.Intrathecal drug administration in chronic pain syndromes.The appropriate use of neurostimulation: avoidance and treatment of complications of neurostimulation therapies for the treatment of chronic pain. Neuromodulation Appropriateness Consensus Committee.Intrathecal drug delivery for chronic pain management-scope, limitations and future.The use of 10-kilohertz spinal cord stimulation in a cohort of patients with chronic neuropathic limb pain refractory to medical management.The Neurostimulation Appropriateness Consensus Committee (NACC) Recommendations for Infection Prevention and Management.Hydrogels for central nervous system therapeutic strategies.Spinal Cord Stimulator Related Infections: Findings From a Multicenter Retrospective Analysis of 2737 Implants.Complications of Spinal Cord Stimulation and Peripheral Nerve Stimulation Techniques: A Review of the Literature.Surgical Site Infections in Cancer Patients with Intrathecal Drug Delivery Devices.An engineered biocompatible drug delivery system enhances nerve regeneration after delayed repair.Management of infections associated with neurosurgical implanted devices.Spinal Cord Stimulator Implant Infection Rates and Risk Factors: A Multicenter Retrospective Study.The Neurostimulation Appropriateness Consensus Committee (NACC) Safety Guidelines for the Reduction of Severe Neurological Injury.Acute exacerbation of hereditary coproporphyria mimics early surgical infection following intrathecal pump implantation for chronic abdominal pain: A case report.Intrathecal midazolam as supplementary analgesia for chronic lumbar pain--15 years' experience.Implementing the SAFE Principles for the Development of Pain Medicine Therapeutic Algorithms That Include Neuromodulation Techniques.An Open-Label, Multicenter Study of the Safety and Efficacy of Intrathecal Ziconotide for Severe Chronic Pain When Delivered via an External Pump.A new spinal cord stimulation system effectively relieves chronic, intractable pain: a multicenter prospective clinical study.Intrathecal baclofen pump infection treated by adjunct intrareservoir teicoplanin instillation.Sustained delivery of bioactive neurotrophin-3 to the injured spinal cord.Infectious Complications of Intrathecal Drug Administration Systems for Spasticity and Chronic Pain: 145 Patients From a Tertiary Care Center.A comment on vadera et Al. "Intrathecal granuloma and intramedullary abscess associated with an intrathecal morphine pump".Infection rate of spinal cord stimulators after a screening trial period. A 53-month third party follow-up.Hydrogel-delivered brain-derived neurotrophic factor promotes tissue repair and recovery after stroke.
P2860
Q26823929-7A598186-8AF8-48F5-92D8-C667BFF215B7Q30360746-BF94E955-EA14-44B6-A6D6-D300A4E23260Q34113244-DF2A09D1-8DE7-401D-AF37-984D89740BE7Q34399168-DDBDFFBA-54AB-4A17-816E-009C654AA409Q36055939-64235909-96BD-407F-85DC-0DA2316BD15DQ36110427-4B785B0E-CEB4-4663-9003-DB0CCE5D4868Q36916995-EA3AADF3-37A6-4022-A0C8-69ABB0A632EBQ37849343-546F0C35-54D7-45A6-A73F-613D4B7B7ADCQ37944887-D4BB472C-B6E0-4584-B3E3-F308B4B6181BQ37965987-2C9B410D-0321-4850-8973-FA0BB0D81AD9Q37995554-7E9A9314-4911-4CE9-936E-3164EA29A953Q38044484-9167B88A-C84B-4574-A5B6-631543485B18Q38084721-7568193B-077A-43D3-980B-21DEA5B782DBQ38151939-4EDC9948-06EF-4C10-B015-E0ACC99D35D5Q38238969-6D065937-B8D3-4418-B154-DDABAB17ED34Q38244848-44A04526-A620-438D-9CCF-AA5EFD41AA8EQ38254463-2CDBE609-6908-4F4A-9BD8-280BAB4D211CQ38434080-1AEE2663-E6EC-4631-95CD-58A82CC4D60AQ38651258-D6D704CF-70F6-4C9B-86B6-3830C145DF99Q38670859-29CD8BD6-8ADF-49B8-8443-5566489EAA57Q38712828-3B3E3743-C96B-4CE1-B72E-628580FBCBE6Q38828812-5B6DED16-FEAD-4DA0-A676-7E9614031488Q38832831-0B0B33AB-81BF-45AE-A778-B23706B857D9Q39026854-9535BB3C-D3A2-42BE-91FB-43701DB93EA7Q39155825-E8444312-7F79-4D4B-B6FC-3106999E8EDFQ39161808-9ACE2FB4-A2A8-4AED-8A78-729B935F3CC7Q39257765-D50D4C76-5F23-4F55-9D8C-B3EBA3E5EDFAQ39259434-9F5486D4-78B2-4EDA-87E7-F46EE218E799Q39305673-B58BA1D2-8239-47A1-B4E4-F6781AFEBD6DQ39321764-E124EEAA-24D8-4F39-960E-37C731AA629FQ39333579-39AA3C8C-685D-4D7C-9D0E-4B67730AB536Q40231624-627A2421-F29C-48F2-9BE6-14502A540327Q40692532-8B6E36BB-0C14-4042-B0BA-07B6798890E3Q41549743-35A90622-E9BA-4894-AAE8-A45D3A92663DQ42723043-BADD810E-4DE8-430A-B3D2-3C892A6C884CQ48222920-D40AF8B6-8CE5-49F1-ADA2-4A9025EE6A94Q48738767-3C4686D0-33A3-47DF-88C5-0B214006F44B
P2860
Prevention and management of intrathecal drug delivery and spinal cord stimulation system infections.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Prevention and management of i ...... stimulation system infections.
@ast
Prevention and management of i ...... stimulation system infections.
@en
type
label
Prevention and management of i ...... stimulation system infections.
@ast
Prevention and management of i ...... stimulation system infections.
@en
prefLabel
Prevention and management of i ...... stimulation system infections.
@ast
Prevention and management of i ...... stimulation system infections.
@en
P2093
P1433
P1476
Prevention and management of i ...... stimulation system infections.
@en
P2093
James M Drake
Kenneth A Follett
Michael S Turner
Richard L Boortz-Marx
Robert J Coffey
Steven J Schneider
Stuart DuPen
P304
P356
10.1097/00000542-200406000-00034
P407
P577
2004-06-01T00:00:00Z